Visceral leishmaniasis complicating a connective tissue disease: Three case reports from Italy

Lupus

Volumn 13, Issue 3, 2004, Pages 201-203

  Castellino, Gabriella ^a   Govoni, M ^a   Lo Monaco, A ^a   Montecucco, C ^b   Colombo, F ^c   Trotta, F ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

Connective tissue diseases; Immunosuppressive therapy; Leishmania donovani; Pancytopenia; Splenomegaly

Indexed keywords

AMPHOTERICIN B; CYCLOPHOSPHAMIDE; DEFLAZACORT; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; MALE; POLYARTHRITIS; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TEMPORAL ARTERITIS; TREATMENT OUTCOME; VISCERAL LEISHMANIASIS;

ADULT; AGED; AMPHOTERICIN B; CONNECTIVE TISSUE DISEASES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ITALY; LEISHMANIASIS, VISCERAL; MALE; PROGNOSIS; RISK ASSESSMENT; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 1842681796     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Hellmann DB, Petri M, Whiting-O'Keefe Q. Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms. Medicine (Baltimore) 1987; 66: 341-348.
2. Badaro R, Carvalho EM, Rocha H, Queiroz AC, Jones TC. Leishmania donovani: an opportunistic microbe associated with progressive disease in three immunocompromised patients. Lancet 1986; i: 647-648.
3. Wallis PJ, Clark CJ. Visceral leishmaniasis complicating systemic lupus erythematosus. Ann Rheum Dis 1983; 42: 201-202.
4. Fernandez-Guerrero ML, Aguado JM, Buzon C et al. Visceral leishmaniasis in immunocompromised hosts. Am J Med 1987; 83: 1098-1102.
5. Granel B, Serratrice J, Swiader L et al. Crossing of antinuclear antibodies and anti-leishmania antibodies. Lupus 2000; 9: 548-550.
6. Braun J, Sieper J, Schulte KL, Thiel E, Janitschke K. Visceral leishmaniasis mimicking a flare of systemic lupus erythematosus. Clin Rheumatol 1991; 10: 445-448.
7. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
8. Ossandon A, Bompane E, Marocchi F et al. Febbre, splenomegalia, ipergammaglobulinemia: lupus eritematoso sistemico e leishmaniasi viscerale. Reumatismo 2002; 54 (S2): 385 (abstract).
9. Gardener-Medwin M, Powell R. One patient, two unusual conditions and three basic lessons. Ann Rheum Dis 1996; 55: 350-352.
10. Broelkaert-Van Orshoven A, Michielson P, Van Despitte J. Fatal leishmaniasis in renal transplant patient. Lancet 1979; ii: 740-741.
11. Murray HW, Rubin BY, Rothermel CD. Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine. J Clin Invest 1983; 72: 1506-1510.
12. Galanakis E, Siamopoulou A, Lapatsanis PD. Leishmaniasis mimicking collagen disease. Lancet 1997; 350: 368-369.